AAPL -1.65%
AMD +1.72%
AMZN -1.57%
ARKK +1.43%
AVGO +1.79%
AXP -2.18%
BEP -1.79%
BLK -1.37%
BRK.A -0.74%
BRK.B -0.45%
CGAU +6.19%
DASH +1.72%
FDX -0.71%
GLD +1.64%
GOOG -0.41%
HD -2.59%
ISRG -5.21%
KO +0.33%
LCID -3.44%
LYFT -0.60%
MSFT -0.50%
NFLX +0.10%
NVDA +0.00%
PLTR -0.09%
PYPL +1.57%
QCOM +0.19%
SNAP +0.00%
UBER +2.05%
UPS +0.05%
VOO -0.49%
News
Mom suffering from postpartum depression Prostock-studio | Shutterstock

Treatment gap leaves new mothers without care as untreated postpartum depression costs $14.2 billion

Despite growing public awareness around maternal healthcare, the vast majority of mothers facing perinatal mental health challenges continue to go without medical support. Perinatal mental health conditions affect approximately 1 in 5 new mothers each year, yet 75.0% of affected women go entirely untreated.

The medical system's failure to connect mothers with timely care persists even as new treatment options reach the market. For instance, when federal regulators in the United States approved Zurzuvae in 2023 as the first oral medication specifically designed for postpartum depression, it was expected to transform treatment options. However, a recent analysis by Simmrin Law Group reveals that only 2.0% of eligible postpartum depression patients have received prescriptions for the medication since its launch.

Advertisement

Rather than signalling a lack of need, this ultra-low adoption rate highlights broader structural barriers within modern healthcare systems:

The best of Money.ca delivered weekly.

By signing up, you accept Money.ca Terms of Use, Subscription Agreement, and Privacy Policy.

  • Insurance friction: Insurance protocols frequently require patients to try and fail on older, general antidepressants before granting access to newer, specialized postpartum therapies.
  • Opaque guidelines: Fewer than 1.0% of health coverage providers publish clear, timely guidelines for newer oral postpartum therapies, leaving doctors and patients navigating complex authorization procedures during critical post-birth windows.

The economic and human toll

The failure to address perinatal mental health creates severe financial and medical consequences that ripple across healthcare infrastructure.

Financial impact

Data compiled by health research organization Mathematica underscores the massive financial drain caused by delayed intervention:

  • $14.2 billion annual burden: The overall economic cost driven by untreated perinatal mood and anxiety disorders in large-scale patient cohorts.
  • $32,000 per mother-infant pair: The average long-term cost in additional healthcare, social service utilization and lost productivity when a mother does not receive treatment.

Must Read

Join 19,000+ readers and get Money.ca’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

Severe health consequences

Beyond financial metrics, missing or delayed care carries tragic human costs. Data from the Centers for Disease Control and Prevention indicates that mental health conditions — including suicide and overdose linked to underlying mood disorders — are the leading cause of pregnancy-related deaths, accounting for 27.7% of maternal fatalities. By comparison, severe hemorrhage accounts for 14.0%.

Medical professionals emphasize that standard postpartum checkups often end too early. Peak onset for severe postpartum mood disruption typically occurs three to six months after delivery, while suicide risk peaks between nine and 12 months postpartum. Without sustained screening, vulnerable patients routinely slip through systemic gaps.

Regional care disparities

Access to care is also heavily dictated by geography. Research from the Policy Center for Maternal Mental Health identifies more than 150 regions across North America as maternal mental health "Dark Zones" — areas completely lacking basic psychiatric resources, specialized clinicians, or adequate support structures for new mothers.

In these underserved regions, the absence of specialized providers compounds social stigmas surrounding maternal mental health. When untreated symptoms escalate in isolated environments, delays in care frequently lead to emergency hospitalizations and severe health crises that proactive screening could prevent.

Closing this care gap will require comprehensive reform: streamlining coverage authorization, expanding routine screening well past the immediate post-birth window, and increasing direct investment in regional healthcare infrastructure.

You May Also Like

The most expensive financial mistakes are often the ones you don't see coming. Join 19,000+ Canadians who get the money moves, risks and opportunities shaping their finances — delivered free each week. Subscribe now.

Share this:
Leslie Kennedy Senior Content Manager

Leslie Kennedy served as an editor at Thomson Reuters and for Star Media Group, followed by a number of years as a writer and editor and content manager in marketing communications, before returning to her editorial roots. She is a graduate of Humber College’s post-graduate journalism program and has been a professional writer and editor ever since.

more from Leslie Kennedy

Explore the latest

Disclaimer

The content provided on Money.ca is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.